Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection
- PMID: 35908456
- DOI: 10.1016/j.clinimag.2022.07.007
Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection
Abstract
Purpose: This study evaluated feasibility and patient outcomes for targeted axillary lymph node (LN) dissection (TAD) with SAVI SCOUT® ultrasound-guided radar reflector localization (RRL).
Methods: In this IRB-approved retrospective study, 800 consecutive patients who underwent ultrasound-guided RRL between November 2017 and June 2020 were reviewed. Of these patients, those with axillary LN RRL were included in this study. Reports in the electronic medical record were reviewed to determine RRL placement, retrieval, and surgical outcomes.
Results: A total of 147 patients met inclusion criteria. Of these, axillary RRL was performed for biopsy-proven metastatic disease in 134 and inconclusive or benign biopsy in 13. RRL was successful in 146/151 lymph nodes (97%). Two patients had placement >10 mm from target and 3 had no post-placement signal. In all 5, the targets were successfully retrieved at surgery. Specimen radiographs were performed in 135 cases and confirmed the intended target in all 135 (100%). In 109 patients who underwent TAD + sentinel lymph node biopsy (SLNB), the RRL LN and the SLN(s) were different in 18 (17%). In 3 of these, the RRL LN was the only malignant LN (3%). In the 105 patients who underwent neoadjuvant chemotherapy, 43% (45/105) achieved nodal pCR and 85% (89/105) had <3 metastatic lymph nodes at surgery.
Conclusion: Ultrasound-guided RRL of axillary LNs is a feasible approach to facilitate TAD with high placement and retrieval success rates. This enables TAD as an alternative to complete axillary LN dissection (cALND), sparing some patients with low nodal tumor burden from cALND.
Keywords: Axillary lymph nodes; Breast cancer; Radar reflector localization; Targeted axillary dissection.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Evaluating Radar Reflector Localisation in Targeted Axillary Dissection in Patients Undergoing Neoadjuvant Systemic Therapy for Node-Positive Early Breast Cancer: A Systematic Review and Pooled Analysis.Cancers (Basel). 2024 Mar 29;16(7):1345. doi: 10.3390/cancers16071345. Cancers (Basel). 2024. PMID: 38611023 Free PMC article. Review.
-
Radar reflector guided axillary surgery in node positive breast cancer patients.Expert Rev Med Devices. 2022 Oct;19(10):791-795. doi: 10.1080/17434440.2022.2139177. Epub 2022 Nov 8. Expert Rev Med Devices. 2022. PMID: 36345879
-
SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study.Breast Cancer Res Treat. 2022 Jan;191(1):107-114. doi: 10.1007/s10549-021-06416-z. Epub 2021 Oct 15. Breast Cancer Res Treat. 2022. PMID: 34652548 Clinical Trial.
-
Efficacy of Targeted Axillary Dissection With Radar Reflector Localization Before Neoadjuvant Chemotherapy.J Surg Res. 2024 Mar;295:597-602. doi: 10.1016/j.jss.2023.11.061. Epub 2023 Dec 13. J Surg Res. 2024. PMID: 38096773
-
Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature.Arch Gynecol Obstet. 2020 Feb;301(2):341-353. doi: 10.1007/s00404-019-05428-x. Epub 2020 Jan 2. Arch Gynecol Obstet. 2020. PMID: 31897672
Cited by
-
An associate of suspicious axillary node and sentinel node in breast cancer to minimizing axillary surgery, prospective cohort study.Ann Med Surg (Lond). 2024 Oct 17;86(12):6936-6943. doi: 10.1097/MS9.0000000000002616. eCollection 2024 Dec. Ann Med Surg (Lond). 2024. PMID: 39649874 Free PMC article.
-
Current Indications for Seed-Marked Axillary Lymph Node Dissection in Breast Cancer.Cancers (Basel). 2025 May 16;17(10):1682. doi: 10.3390/cancers17101682. Cancers (Basel). 2025. PMID: 40427179 Free PMC article.
-
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.Breast Cancer Res Treat. 2025 May;211(1):203-211. doi: 10.1007/s10549-025-07635-4. Epub 2025 Feb 20. Breast Cancer Res Treat. 2025. PMID: 39976867
-
Evolution of localization methods for non-palpable breast lesions: a literature review from a translational medicine perspective.Transl Breast Cancer Res. 2024 Apr 15;5:12. doi: 10.21037/tbcr-23-49. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 38751684 Free PMC article. Review.
-
Evaluating Radar Reflector Localisation in Targeted Axillary Dissection in Patients Undergoing Neoadjuvant Systemic Therapy for Node-Positive Early Breast Cancer: A Systematic Review and Pooled Analysis.Cancers (Basel). 2024 Mar 29;16(7):1345. doi: 10.3390/cancers16071345. Cancers (Basel). 2024. PMID: 38611023 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous